Genmab | GEN - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Almirall EUR 175.93M 17.87M 2025-12
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.14B 432M 2026-03
argenx SE USD 1.66B 458.83M 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Bayer EUR 18.55B 4.36B 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Demant DKK 5.5B 262M 2025-12
Exelixis USD 328.95M 42.03M 2026-03
Fresenius Medical Care EUR 3.72B 58.09M 2026-03
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
GN Store Nord DKK 2.44B 2.86B 2026-03
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Insmed USD 178.55M 37.7M 2026-03
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.81B 373M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12